Press Releases

Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation to further develop…

Nucleai Secured $6.5m Series-A Initial Closing Led by Debiopharm to Advance Ai-Powered Precision Oncology Platform

Acquisition of Debiopharm’s Investment Portfolio Company Kaiku Health Broadens Patient Access to Digital Oncology Intervention

Novadiscovery raises series A financing to scale its in silico clinical trial platform – Debiopharm leads the round with EUR…

Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics

Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test

Debiopharm invests double digit millions in the Canadian startup GenePOC, specialized in the development of rapid diagnostic tests